Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Jordan Snyder, PharmD, BCOP
Advertisement
Articles by Jordan Snyder, PharmD, BCOP
Tracking PDUFA decisions and early planning can lead to safe, rapid access to new medications for patients.
Advertisement
Latest Updated Articles
Approval Pending: How to Plan for PDUFA DecisionsApril 23rd 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 ‘Is Not Done With Us’: Pharmacist Urges Continued Vaccination Ahead of Seasonal Peaks
2
Tarlatamab and Next-Generation Targeted Agents Headline ESMO 2026 Lung Cancer Data
3
Cystatin C and the Future of Kidney Function Assessment
4
Ribociclib Survival Data Anchor a Sobering ESMO 2026 for Breast Cancer
5